SELVAS Healthcare Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chul-Joong Kwon

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	no data
Board average tenure	no data

Recent management updates

Recent updates

Investors Shouldn't Be Too Comfortable With SELVAS Healthcare's (KOSDAQ:208370) Earnings

Mar 27

Is SELVAS Healthcare (KOSDAQ:208370) Using Too Much Debt?

Mar 11

SELVAS Healthcare's (KOSDAQ:208370) Stock Price Has Reduced 62% In The Past Three Years

Jan 26

What Do The Returns At SELVAS Healthcare (KOSDAQ:208370) Mean Going Forward?

Jan 03

We Wouldn't Rely On SELVAS Healthcare's (KOSDAQ:208370) Statutory Earnings As A Guide

Dec 08

CEO

Chul-Joong Kwon (58 yo)

no data

Tenure

Mr. Chul-Joong Kwon Chief Executive Officer of SELVAS Healthcare, Inc. Mr. Kwon serves as Chief Executive Officer and Vice President at DIOTEK Co., Ltd. and is in Charge of Business Division 1. He served a...

SELVAS Healthcare Management

Management criteria checks 0/4

Key information

Recent management updates

Less than half of directors are independent

Less than half of directors are independent

SELVAS Healthcare, Inc., Annual General Meeting, Mar 30, 2021

Recent updates

New minor risk - Market cap size

Investors Shouldn't Be Too Comfortable With SELVAS Healthcare's (KOSDAQ:208370) Earnings

Investor sentiment deteriorates as stock falls 16%

New minor risk - Shareholder dilution

SELVAS Healthcare, Inc. has completed a Follow-on Equity Offering in the amount of KRW 20.876441 billion.

SELVAS Healthcare, Inc. agreed to acquire a 2.72% stake in Ultrasight Ltd. for KRW 1.4 billion.

SELVAS Healthcare, Inc. agreed to acquire a 2.72% stake in Ultrasight Ltd. for KRW 1.4 billion.

Investor sentiment deteriorates as stock falls 24%

Investor sentiment improves as stock rises 21%

Investor sentiment deteriorates as stock falls 31%

Investor sentiment improves as stock rises 35%

Investor sentiment improves as stock rises 27%

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: ₩81.00 loss per share (vs ₩17.00 loss in 1Q 2020)

Full year 2020 earnings released: EPS ₩35.00 (vs ₩239 loss in FY 2019)

Is SELVAS Healthcare (KOSDAQ:208370) Using Too Much Debt?

SELVAS Healthcare, Inc., Annual General Meeting, Mar 30, 2021

SELVAS Healthcare's (KOSDAQ:208370) Stock Price Has Reduced 62% In The Past Three Years

New 90-day high: ₩2,595

What Do The Returns At SELVAS Healthcare (KOSDAQ:208370) Mean Going Forward?

We Wouldn't Rely On SELVAS Healthcare's (KOSDAQ:208370) Statutory Earnings As A Guide

New 90-day high - ₩2,750

New 90-day low - ₩2,025

CEO

Tenure